Drug Executive Collapses During Oval Office Press Conference
A press event in the Oval Office was interrupted when a drug executive fainted as President Donald Trump announced a new agreement with pharmaceutical companies to cut obesity drug prices.
Details of the Incident
The incident occurred while Trump and representatives from Eli Lilly and Novo Nordisk discussed expanding coverage and reducing prices for obesity treatments Zepbound and Wegovy. During the remarks, Eli Lilly CEO David Ricks noticed the situation and asked,
“Are you okay? Gordon, are you okay?”
The individual who collapsed was identified as Gordon Findlay, Novo Nordisk's global brand director.
Response and Aftermath
Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, immediately assisted as Findlay fell to his knees and collapsed. The press was promptly asked to leave the room following the incident. Health and Human Services Secretary was also present during the event.
About 30 minutes later, when the conference resumed, President Trump provided an update on the executive’s condition.
President Donald Trump looks on as Administrator Dr. Mehmet Oz and others assist Gordon Findlay during the incident.
Author's summary: During a press briefing on drug price reductions, Novo Nordisk’s Gordon Findlay collapsed in the Oval Office, prompting immediate medical aid and a temporary pause in the event.